Alnylam Pharmaceuticals
ALNY
#649
Rank
A$56.93 B
Marketcap
A$426.42
Share price
2.04%
Change (1 day)
-14.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company